Status:
COMPLETED
Therapeutic Diets in Alzheimer's Disease
Lead Sponsor:
University of Kansas Medical Center
Collaborating Sponsors:
National Institute on Aging (NIA)
Conditions:
Alzheimer Disease
Eligibility:
All Genders
50-90 years
Phase:
NA
Brief Summary
By doing this study, researchers hope to learn how the ketogenic and Therapeutic Lifestyles Changes diets affect cognition in patients with Alzheimer's disease.
Eligibility Criteria
Inclusion
- Diagnosis of AD by current McKhann et al. criteria
- CDR global score of 0.5 or 1
- Agreed cooperation from an appropriate study partner
- Speaks English as primary language
- Age 50 to 90
- No medication changes within the past 30 days
Exclusion
- Resides in a nursing home or dementia special care unit, or cannot control diet
- A potentially confounding serious medical risk including insulin-requiring diabetes, cancer requiring chemotherapy or radiation within the past 5 years, or a recent cardiac event (i.e. heart attack, angioplasty, etc.)
- Participating in another clinical trial or using an investigational drug or therapy within 30 days of the Screening Visit
- A history of renal stones
Key Trial Info
Start Date :
October 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 20 2025
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT03860792
Start Date
October 15 2019
End Date
June 20 2025
Last Update
December 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical and Translational Science Unit
Fairway, Kansas, United States, 66205